EG669998 Activators

Class II transactivator activators consist of various chemical compounds that can influence the expression and activity of CIITA, which coordinates the transcription of MHC class II genes necessary for antigen presentation. Compounds like Amlexanox and Pyrimethamine indirectly enhance CIITA activity by modulating the activity of kinases and enzymes involved in metabolic and signaling pathways that affect transcription factors directly responsible for CIITA expression. Amlexanox's inhibition of IKK-epsilon and TBK1 kinases leads to the activation of IRF3, a transcription factor known to upregulate CIITA. Pyrimethamine's inhibition of dihydrofolate reductase can cause the accumulation of metabolites that act as co-factors for transcription factors, thereby enhancing the expression of CIITA.

Chemicals such as Chloroquine and Rolipram impact endosomal signaling and cyclic AMP (cAMP) levels, respectively, leading to activation of pathways involving NF-kB, a known regulator of CIITA transcription. Chloroquine disrupts endosomal acidification, affecting TLR signaling and consequent NF-kB activation, while Rolipram's inhibition of phosphodiesterase 4 raises cAMP, which activates PKA and ultimately can enhance CIITA transcription. Epigenetic modifiers like 5-Azacytidine and Trichostatin A also play a role by demethylating the CIITA promoter or by increasing histone acetylation, leading to an open chromatin state conducive to its transcription. Resveratrol's activation of SIRT1 and the actions of sulforaphane and oltipraz on Nrf2 demonstrate how modifying the activity of transcription factors and nuclear receptors can indirectly enhance CIITA expression.